Core Insights - UnitedHealth Group Incorporated (UNH) and Centene Corporation (CNC) are key players in the healthcare industry, benefiting from increasing healthcare demand, an aging population, and a rise in chronic diseases [1] - UnitedHealth is in a strong leadership position with steady execution, while Centene is undergoing a turnaround focused on efficiency and margin recovery [2] UnitedHealth Overview - UnitedHealth has a market cap of $250.1 billion and operates with a dual-engine model, combining insurance through UnitedHealthcare and technology-enabled health services via Optum [4] - The company reported a 12% revenue growth in its latest quarter, driven by growth in commercial fee-based membership and Optum Rx [5] - Despite the revenue growth, adjusted earnings fell by 69% year over year due to high medical costs and a decline in risk-based membership [5] - UnitedHealth's profitability is supported by its scale, data integration, and care delivery capabilities, with estimated operating cash flows of $18 billion in 2026 [6] - The company plans to repurchase $2.5 billion in shares and pay $8 billion in dividends [6] Centene Overview - Centene has a market cap of $16.9 billion and focuses heavily on government-sponsored programs, particularly Medicaid, which exposes it to policy changes [8] - In its most recent quarter, Centene's revenues increased by 21.9% year over year, but it reported a loss of $1.19 per share compared to earnings of 80 cents per share a year ago [9] - The company is working on margin recovery by exiting underperforming markets and repricing contracts, but faces structural challenges [9] - Centene's return on invested capital is 3.76%, lower than UnitedHealth's 5.37% [9] Financial Comparisons - UnitedHealth's margins and cash flow are stronger compared to Centene, which has higher risk and is in a turnaround phase [10] - Centene's medical loss ratio (HBR) is projected to be between 90.9% and 91.7% for 2026, while UnitedHealth expects a medical cost ratio (MCR) of 88.8% [11] - Centene's long-term debt-to-capital ratio is 46.45%, higher than UnitedHealth's 42.48%, indicating greater financial leverage [12] Earnings Estimates - For UnitedHealth, the Zacks Consensus Estimate forecasts 2026 EPS of $17.70, reflecting an 8.3% year-over-year growth [13] - Centene's 2026 earnings estimate stands at $3.05 per share, implying a 46.6% year-over-year growth as cost pressures ease [14] Valuation and Price Performance - UnitedHealth trades at a forward P/E of 15.17X, while Centene trades at 10.51X, reflecting UnitedHealth's superior earnings visibility and lower risk [15] - Over the past month, UnitedHealth's shares gained 0.6%, outperforming Centene and the broader market [17] - UnitedHealth's average price target suggests a 28.1% upside, while Centene's indicates a 23.7% upside [20] Conclusion - Both companies are positioned to benefit from long-term healthcare trends, but UnitedHealth offers greater stability and a more consistent growth trajectory compared to Centene's uncertain outlook [21][22]

Has anyone told you today that they believe in you and that you under 18 hold the key to solve one of the biggest problems we have in this world today because I do and my team does. Seriously, you can save us adults from the chronic diseases half of us are dealing with. I will tell you how.So, we're on a slightly ambitious mission to help the over 500 million children struggling with overweight and obesity across this globe. And last week, I met Emily and her mom. Emily is 12 years old, has been struggling ...